Sequent Scientific Ltd Faces Technical Momentum Shift Amid Mixed Market Signals

Technical Trend Overview

Sequent Scientific’s technical trend has shifted from mildly bullish to sideways, reflecting a period of consolidation after recent price fluctuations. The stock closed at ₹189.40 on 14 Jan 2026, down 1.61% from the previous close of ₹192.50. Intraday trading saw a high of ₹193.75 and a low of ₹188.65, indicating a relatively narrow trading range amid cautious investor sentiment.

The 52-week price range remains wide, with a high of ₹260.30 and a low of ₹111.00, underscoring significant volatility over the past year. This volatility is mirrored in the technical indicators, which present a mixed picture across different timeframes.

MACD Signals: Divergent Weekly and Monthly Perspectives

The Moving Average Convergence Divergence (MACD) indicator reveals a divergence between weekly and monthly trends. On the weekly chart, the MACD is mildly bearish, suggesting short-term momentum is weakening. This bearishness is consistent with the recent price decline and sideways movement, signalling that the stock may face resistance in the near term.

Conversely, the monthly MACD remains bullish, indicating that the longer-term momentum retains strength. This suggests that while short-term traders may exercise caution, longer-term investors could find value in the stock’s underlying fundamentals and sector positioning.

RSI and Bollinger Bands: Neutral to Bearish Signals

The Relative Strength Index (RSI) on both weekly and monthly charts currently shows no clear signal, hovering in neutral territory. This lack of momentum extremes implies that the stock is neither overbought nor oversold, reinforcing the sideways trend narrative.

Bollinger Bands add further nuance: weekly bands are bearish, reflecting increased volatility and downward pressure, while monthly bands are mildly bullish, suggesting that the stock’s price remains within a broader upward channel over the longer term.

Moving Averages and KST: Mixed Momentum Indicators

Daily moving averages provide a mildly bullish signal, with short-term averages slightly above longer-term averages. This indicates some underlying buying interest, although the strength is insufficient to overcome the broader sideways trend.

Meanwhile, the Know Sure Thing (KST) oscillator is mildly bearish on both weekly and monthly charts, signalling that momentum may be waning across multiple timeframes. This bearishness aligns with the MACD weekly outlook and suggests caution for traders seeking momentum-driven opportunities.

Dow Theory and On-Balance Volume (OBV): Bearish to Neutral

Dow Theory assessments on weekly and monthly charts are mildly bearish, indicating that the stock’s price action is not confirming a strong uptrend. This is a critical consideration for investors relying on trend confirmation to time entries and exits.

The OBV indicator is mildly bearish on the weekly chart, reflecting selling pressure, while the monthly OBV shows no clear trend. This divergence suggests that volume-based momentum is weakening in the short term but remains inconclusive over the longer horizon.

Mojo Score and Grade Change

MarketsMOJO has downgraded Sequent Scientific’s Mojo Grade from Hold to Sell as of 13 Jan 2026, with a current Mojo Score of 40.0. The downgrade reflects the deteriorating technical outlook and the stock’s underperformance relative to benchmarks. The Market Cap Grade stands at 3, indicating a mid-tier market capitalisation within its sector.

This downgrade is significant for investors who incorporate technical grading into their decision-making, signalling a need for caution or potential portfolio rebalancing.

Price Performance Relative to Sensex

Sequent Scientific’s recent price returns have lagged behind the broader Sensex index, highlighting sector-specific or company-specific challenges. Over the past week, the stock declined by 8.55%, compared to the Sensex’s 1.69% fall. Similarly, the one-month return was down 9.72% versus the Sensex’s 1.92% decline, and year-to-date losses stand at 9.01% against the Sensex’s 1.87% drop.

However, the stock has outperformed over longer horizons. The one-year return is 10.89%, slightly ahead of the Sensex’s 9.56%. More impressively, the three-year return is 122.04%, significantly surpassing the Sensex’s 38.78%, reflecting strong historical growth. The five-year return, however, is modest at 1.99%, lagging the Sensex’s 68.97%, and the ten-year return is negative at -9.68%, compared to the Sensex’s robust 236.47% gain.

This mixed performance underscores the importance of timeframe in evaluating Sequent Scientific’s investment potential.

Sector and Industry Context

Operating within the Pharmaceuticals & Biotechnology sector, Sequent Scientific faces sector-wide headwinds including regulatory scrutiny, pricing pressures, and competitive innovation. The sector’s inherent volatility is reflected in the stock’s technical indicators and price action.

Investors should weigh these sector dynamics alongside the company’s technical signals to form a comprehensive view of risk and opportunity.

Investor Takeaway and Outlook

Sequent Scientific Ltd’s recent technical momentum shift and downgrade to a Sell grade by MarketsMOJO reflect a cautious near-term outlook. The mixed signals from MACD, RSI, Bollinger Bands, and other momentum indicators suggest that the stock is in a consolidation phase, with short-term bearish pressures counterbalanced by longer-term bullish trends.

Investors should consider the stock’s underperformance relative to the Sensex in the short term, alongside its strong three-year growth record, when making portfolio decisions. The mildly bearish volume and trend indicators advise prudence, particularly for momentum traders, while longer-term investors may find opportunities if the stock stabilises and resumes upward momentum.

Given the sector’s volatility and the stock’s technical complexity, a balanced approach incorporating both fundamental and technical analysis is recommended.

Summary of Key Technical Metrics:

• Current Price: ₹189.40 (14 Jan 2026)


• 52-Week Range: ₹111.00 - ₹260.30


• Mojo Score: 40.0 (Sell Grade)


• MACD: Weekly Mildly Bearish, Monthly Bullish


• RSI: Neutral (Weekly & Monthly)


• Bollinger Bands: Weekly Bearish, Monthly Mildly Bullish


• Moving Averages: Daily Mildly Bullish


• KST: Mildly Bearish (Weekly & Monthly)


• Dow Theory: Mildly Bearish (Weekly & Monthly)


• OBV: Mildly Bearish Weekly, No Trend Monthly

Investors should monitor upcoming earnings, sector developments, and technical indicator shifts closely to reassess the stock’s trajectory.

Unlock special upgrade rates for a limited period. Start Saving Now →